AeroVironment
AVAV
138.86
-4.68
-3.26%
AeroVironment
US · AVAV
#1759 by market cap
Listed 1970
138.86
-4.68
-3.26%
Live - 5344 symbols - heartbeat 398s ago
· 2026-10-08 08:29
Pre-market
137.50
-0.98%
After-hours
139.05
+0.14%
Overnight
138.06
-0.58%
- Market cap
- 7.06B
- P/E (TTM)i
- -34.20
- P/Bi
- 1.61
- EPSi
- -5.40
- Div yieldi
- 0.00%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on AVAV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.83, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +140.89% YoY
Margins
- Gross margin
- 25.33%
- Operating margin
- -3.56%
- Net margin
- -13.41%
Key ratios & quality
- Enterprise valuei
- 7.17B
- Altman Z-Scorei
- 3.83
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 314.27M | 367.30M | 394.91M | 445.73M | 540.54M | 716.72M | 820.63M | 1.98B |
| Gross profit | 128.40M | 153.10M | 164.56M | 141.24M | 173.51M | 283.93M | 318.64M | 500.64M |
| Selling & admin expenses | 60.34M | 59.49M | 67.48M | 96.43M | 131.91M | 114.42M | 158.75M | 443.25M |
| Research & development | 34.23M | 46.48M | 53.76M | 54.69M | 64.26M | 97.69M | 100.73M | 127.68M |
| Operating profit | 33.83M | 47.14M | 43.31M | -9.89M | -22.65M | 71.82M | 59.15M | -70.29M |
| Pretax profit | 50.48M | 52.67M | 34.37M | -19.14M | -188.38M | 63.23M | 39.66M | -305.62M |
| Tax | 4.64M | 5.85M | 539.00K | -10.37M | -14.66M | 1.89M | 882.00K | -23.06M |
| Net profit | 47.42M | 41.07M | 23.35M | -4.19M | -176.17M | 59.67M | 43.62M | -265.12M |
| Basic EPS | 2 | 2 | 1 | 0 | -7 | 2 | 2 | -5 |
| Diluted EPS | 1.97 | 1.71 | 0.96 | -0.17 | -7.04 | 2.18 | 1.55 | -5.40 |
| Line item | 2025-04 | 2025-08 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 275.05M | 454.68M | 472.51M | 408.05M | 641.62M | 480.49M |
| Gross profit | 100.33M | 95.12M | 104.11M | 98.79M | 202.63M | 124.60M |
| Selling & admin expenses | 43.25M | 131.28M | 98.34M | 99.41M | 114.23M | 111.51M |
| Research & development | 24.90M | 33.11M | 35.99M | 27.11M | 31.46M | 23.96M |
| Operating profit | 32.18M | -69.27M | -30.22M | -27.73M | 56.94M | -10.87M |
| Pretax profit | 13.11M | -84.33M | -20.60M | -265.14M | 64.45M | -7.33M |
| Tax | 223.00K | -15.17M | -2.31M | -21.62M | 16.03M | -397.00K |
| Net profit | 16.66M | -67.37M | -17.10M | -243.82M | 63.17M | -5.07M |
| Basic EPS | 1 | -1 | 0 | -5 | 1 | 0 |
| Diluted EPS | 0.59 | -1.44 | -0.34 | -4.90 | 1.25 | -0.10 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 469.59M | 503.93M | 401.64M | 368.91M | 477.00M | 515.58M | 606.52M | 1.89B |
| Cash & ST investments | 323.20M | 302.65M | 180.71M | 101.95M | 132.86M | 73.30M | 40.86M | 632.30M |
| Inventory | 54.06M | 45.54M | 71.65M | 90.63M | 138.81M | 150.17M | 144.09M | 312.86M |
| Total assets | 508.84M | 584.95M | 928.57M | 914.20M | 824.58M | 1.02B | 1.12B | 5.72B |
| Total current liabilities | 44.87M | 66.95M | 96.19M | 101.39M | 121.33M | 144.88M | 172.16M | 439.24M |
| Short-term debt | -- | 3.38M | 16.15M | 16.82M | 15.73M | 19.84M | 10.48M | 17.59M |
| Long-term debt | -- | -- | 187.51M | 177.84M | 125.90M | 17.09M | 30.00M | 728.97M |
| Total liabilities | 46,269,000.00 | 75,053,000.00 | 316,459,000.00 | 305,990,000.00 | 273,607,000.00 | 193,115,000.00 | 234,060,000.00 | 1,316,342,000.00 |
| Total equity | 462.58M | 509.90M | 612.11M | 608.21M | 550.97M | 822.75M | 886.51M | 4.40B |
| Retained earnings | 286.35M | 328.09M | 351.42M | 347.23M | 171.02M | 230.69M | 274.31M | 9.18M |
| Line item | 2025-04 | 2025-08 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 606.52M | 1.64B | 1.67B | 1.70B | 1.89B | 1.88B |
| Cash & ST investments | 40.86M | 685.80M | 588.48M | 587.14M | 632.30M | 580.23M |
| Inventory | 144.09M | 232.89M | 259.21M | 299.28M | 312.86M | 410.77M |
| Total assets | 1.12B | 5.62B | 5.64B | 5.45B | 5.72B | 5.73B |
| Total current liabilities | 172.16M | 274.93M | 328.03M | 309.32M | 439.24M | 441.73M |
| Short-term debt | 10.48M | 16.76M | 14.83M | 15.57M | 17.59M | 17.82M |
| Long-term debt | 30.00M | 725.70M | 726.79M | 727.88M | 728.97M | 730.06M |
| Total liabilities | 234,060,000.00 | 1,196,958,000.00 | 1,220,385,000.00 | 1,181,446,000.00 | 1,316,342,000.00 | 1,334,638,000.00 |
| Total equity | 886.51M | 4.43B | 4.42B | 4.27B | 4.40B | 4.40B |
| Retained earnings | 274.31M | 206.94M | 189.83M | 33.28M | 9.18M | 4.12M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 19.26M | 25.10M | 86.53M | -9.62M | 11.40M | 15.29M | -1.32M | -78.40M |
| Depreciation & amortization | 7.67M | 9.89M | 19.26M | 60.83M | 100.00M | 35.75M | 41.00M | 265.04M |
| Free cash flow | 10.36M | 13.88M | 75.27M | -31.91M | -3.47M | -9.19M | -24.13M | -164.62M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | 0 | 0 | 104.65M | 88.44M | 0 | 968.52M |
| Ending cash balance | 172.71M | 255.14M | 157.06M | 77.23M | 132.86M | 73.30M | 40.86M | 377.33M |
| Line item | 2025-04 | 2025-08 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | -264.00K | -123.73M | -45.08M | -5.11M | 95.51M | 13.50M |
| Depreciation & amortization | 13.85M | 90.25M | 58.07M | 54.63M | 62.08M | 56.03M |
| Free cash flow | -8.79M | -155.79M | -59.82M | -21.71M | 72.70M | -35.95M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 968.52M | 0 | 0 | 0 | 0 |
| Ending cash balance | 40.86M | 685.80M | 359.43M | 289.88M | 377.33M | 278.39M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 10.87 | 8.45 | 4.16 | -0.69 | -30.41 | 8.69 | 5.10 | -10.03 |
| ROA %i | 9.66 | 7.51 | 3.08 | -0.45 | -20.27 | 6.48 | 4.08 | -7.76 |
| ROIC %i | 9.90 | 7.41 | 3.53 | -0.02 | -21.79 | 7.99 | 4.99 | -8.40 |
| 5-year avg ROE %i | 4.46 | 5.98 | 6.31 | 5.46 | -1.52 | -1.96 | -2.63 | -5.47 |
| EBIT margin %i | 10.76 | 12.83 | 8.86 | -3.07 | -33.12 | 9.41 | 5.10 | -15.18 |
| FCF / sales %i | 3.30 | 3.78 | 19.06 | -- | -- | -- | -- | -- |
| Current ratioi | 10.47 | 7.53 | 4.18 | 3.64 | 3.93 | 3.56 | 3.52 | 4.30 |
| Quick ratioi | 9.10 | 6.75 | 3.27 | 2.63 | 2.69 | 2.37 | 2.52 | 3.47 |
| Debt / assetsi | 0.00 | 1.75 | 23.99 | 23.69 | 19.75 | 5.87 | 5.74 | 14.60 |
| LT debt / equityi | -- | 1.34 | 33.76 | 32.86 | 26.70 | 4.84 | 6.07 | 18.57 |
| Interest coveragei | -- | -- | 56.61 | -2.52 | -19.11 | 15.98 | 19.13 | -53.45 |
| Revenue CAGR (3Y) %i | 10.37 | 16.36 | 13.73 | 12.35 | 13.75 | 21.98 | 22.56 | 54.07 |
| Net income CAGR (3Y) %i | 74.25 | 46.36 | 9.31 | -- | -- | 36.75 | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | 8.06 | -- | -- | -- | -- | -- |
| Line item | 2025-04 | 2025-08 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 5.10 | -1.70 | -2.64 | -8.74 | -10.03 | -4.60 |
| ROA %i | 4.08 | -1.36 | -2.09 | -6.90 | -7.76 | -3.57 |
| ROIC %i | 4.99 | -0.98 | -2.26 | -7.46 | -8.40 | -3.86 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.10 | -4.41 | -6.40 | -6.98 | -15.18 | -12.06 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 3.52 | 5.96 | 5.08 | 5.51 | 4.30 | 4.26 |
| Quick ratioi | 2.52 | 4.98 | 4.15 | 4.40 | 3.47 | 3.19 |
| Debt / assetsi | 5.74 | 14.75 | 14.65 | 15.15 | 14.60 | 14.85 |
| LT debt / equityi | 6.07 | 18.36 | 18.36 | 18.97 | 18.57 | 18.95 |
| Interest coveragei | 19.13 | -2.47 | -- | -- | -53.45 | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Autonomous Systems (AxS) is the largest reported line at 72.00% of revenue, across 2 reported segments.
- The next-largest line, Space, Cyber and Directed Energy (SCDE), is a distant second at 28.00% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Autonomous Systems (AxS)72.00%
Space, Cyber and Directed Energy (SCDE)28.00%
Quote time 2026-10-08 08:29:40 · For reference only, not investment advice and not tailored to your situation.